Improved Forensic DNA Analysis with Spectrum CE and Eight-Color STR Technology
In this webinar, you will learn:
- How the flexibility of the Spectrum CE System improves the forensic DNA laboratory workflow
- That eight-color STR Systems can provide the most usable profile information per amplification
- That together, the Spectrum CE and eight-color PowerPlex® Systems can help solve challenging cases
Summary
When time and samples are limited, getting usable STR profile from every amplification is critical. Together, the Spectrum CE and eight-color PowerPlex® STR Systems maximizes your chance of producing searchable profiles from degraded or inhibited casework samples in a timely manner. Compared to six-color kits, eight-color STR kits have more mini-STR loci that are less likely to drop-out. When there are drop-outs, the Quality Indicators help determine if it is due to degradation or inhibition, thus simplifying and streamlining follow-up actions. The four-plate capacity of the 8-dye capable Spectrum CE System, with each plate being continuously accessible, improves forensic DNA laboratory productivity, eliminates the need to batch samples and reduces scheduling conflicts. Improving laboratory efficiency is key to reducing forensic casework backlogs, solving crimes, and ensuring public safety. Join webinar to learn more.
Speakers
Mary Loten
Global Validation Scientist
Promega
Mary Loten has been a Validation Scientist at Promega for the last seven years. As part of the Validation Services team at Promega, she provides forensic laboratories assistance with all aspects of the validation process which includes planning, on-site bench work, data analysis, and post-validation training. Prior to her current role, she worked as a forensic DNA analyst at a private DNA laboratory and as a research scientist with Promega. She has a Master of Forensic Science Degree from the George Washington University and holds certification from the American Board of Criminalistics.
Michael Lauck, PhD
Senior Research Scientist
Promega
Dr. Michael Lauck is a Senior Research Scientist in the Genetic Identity Group at Promega Corporation. Dr. Lauck started his career at Promega in 2015, focusing on the development of new STR and Capillary Electrophoresis Systems. Prior to joining Promega, he received his Ph.D. in 2013 in Cellular and Molecular Biology at the University of Wisconsin – Madison where he used Next-Generation Sequencing for the discovery and characterization of novel RNA viruses in African non-human primates. He continued his research in pathogen discovery at the Department of Pathology and Laboratory Medicine, also at the University of Wisconsin – Madison, working as a Scientist. Dr. Lauck’s research has been published in leading academic journals such as Cell Host & Microbe, Science Translational Medicine, PNAS, PLoS Pathogens and the Journal of Virology.